Published: Dec. 5, 2023
Language: Английский
Published: Dec. 5, 2023
Language: Английский
Evaluation & the Health Professions, Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 14, 2024
The COVID-19 crisis rapidly introduced telemedicine as the predominate modality to deliver healthcare however this change has not received attention in primary care settings and health-related impacts are unknown. study's objective was explore effects of physician-led synchronous compared face-to-face delivered setting on system use attributes reported recent studies. We performed a comprehensive literature search five databases (MEDLINE, Embase, Cochrane Database Systematic Reviews, Central Register Controlled Trials, PsycInfo) critical appraisal using Joanna Briggs Institute tools. Of 6,247 studies identified, 157 underwent full text review, 19 were included. Most conducted U.S. (78.9%) used video telephone (57.9%). An outcome-based qualitative description narrative synthesis showed similar or fewer emergency department visits, hospital prescribing, diagnostic tests imaging for visits care. Our systematic review fills gap our results need be interpreted cautiously given studies' susceptibility selection bias, confounding, limited applicability other health systems time periods.
Language: Английский
Citations
0medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown
Published: Nov. 18, 2023
Abstract BACKGROUND Telehealth has emerged as an effective tool for managing common chronic conditions such hypertension, especially during the COVID-19 pandemic. However, impact of state telehealth payment and coverage parity laws on hypertension management remains uncertain. METHODS Data from Merative TM MarketScan® Commercial Claims Encounters Database January 1, 2016 to December 31, 2021 were used construct study cohort. The sample included non-pregnant individuals aged 25–64 years with hypertension. We reviewed coded related in all 50 states District Columbia, distinguishing between laws. primary outcomes antihypertension medication use, measured by average possession ratio (MPR), adherence (MPR ≥80%), number days drug supply. a generalized difference-in-difference (DID) design examine these Results presented marginal effects 95% confidence intervals (CI). RESULTS Among 353,220 individuals, significantly linked increased MPR 0.43 percentage point (95% CI: 0.07 - 0.79), increase 0.46 0.06 0.92) probability adherence. Payment also led 2.14 0.11 4.17) antihypertensive supply, after controlling state-fixed effects, year-fixed individual sociodemographic characteristics time-varying covariates including unemployment rates, GDP per capita, poverty rates. In contrast, associated 2.13-day 0.19 4.07) but did not or addition, positively hypertension-related visits, this effect reach statistical significance. These findings consistent sensitivity analyses. CONCLUSIONS State greater adherence, whereas not. With increasing adoption across states, may support policymakers understanding potential implications Clinical Perspective What Is New? is manage state-level can influence its application. Prior studies have clearly differentiated impacts parity. Using quasi-experimental difference-in-differences design, we assessed management. Our found that while Are Implications? widespread management, emergencies like pandemic beyond. Considering approximately half adult population, our provides valuable insights into benefits private payers enhancing integrating holds significant evolving U.S. healthcare system digital age.
Language: Английский
Citations
0Published: Dec. 5, 2023
Language: Английский
Citations
0